Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Significance of HPV-58 infection in women who are HPV-positive, cytology-negative and living in a country with a high prevalence of HPV-58 infection.

Song JS, Kim EJ, Choi J, Gong G, Sung CO.

PLoS One. 2013;8(3):e58678. doi: 10.1371/journal.pone.0058678. Epub 2013 Mar 7.

2.

Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.

Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D; HPV-039 study group..

Int J Cancer. 2014 Dec 1;135(11):2604-11. doi: 10.1002/ijc.28896. Epub 2014 May 20.

3.

Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.

Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M; VALGENT Study Group..

J Clin Microbiol. 2013 May;51(5):1458-64. doi: 10.1128/JCM.00087-13. Epub 2013 Feb 27.

4.

Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.

Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM.

Int J Cancer. 2012 Nov 15;131(10):2349-59. doi: 10.1002/ijc.27485. Epub 2012 Mar 20.

5.

Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable.

Asciutto KC, Henic E, Darlin L, Forslund O, Borgfeldt C.

Acta Obstet Gynecol Scand. 2016 Nov;95(11):1251-1257. doi: 10.1111/aogs.12960. Epub 2016 Sep 6.

PMID:
27513888
6.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

7.

The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study.

Chen CA, Liu CY, Chou HH, Chou CY, Ho CM, Twu NF, Kan YY, Chuang MH, Chu TY, Hsieh CY; Taiwan Cooperative Oncologic Group..

Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1801-8.

PMID:
17009975
8.

Prevalence of human papillomavirus and the correlation of HPV infection with cervical disease in Weihai, China.

Yang L, He Z, Huang XY, Liu HN, Tao JY.

Eur J Gynaecol Oncol. 2015;36(1):73-7.

PMID:
25872339
9.

Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.

Učakar V, Poljak M, Oštrbenk A, Klavs I.

J Med Virol. 2014 Oct;86(10):1772-9. doi: 10.1002/jmv.23997. Epub 2014 Jun 30.

PMID:
24978445
10.
11.

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.

Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.

JAMA. 1999 May 5;281(17):1605-10.

PMID:
10235153
12.

Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India.

Chakravarty J, Chourasia A, Thakur M, Singh AK, Sundar S, Agrawal NR.

Indian J Med Res. 2016 Jan;143(1):79-86. doi: 10.4103/0971-5916.178614.

13.

The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.

Sehnal B, Dusek L, Cibula D, Zima T, Halaska M, Driak D, Slama J.

J Clin Virol. 2014 Jan;59(1):18-23. doi: 10.1016/j.jcv.2013.11.004. Epub 2013 Nov 23.

PMID:
24315797
14.

Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security.

Beby-Defaux A, Bourgoin A, Ragot S, Battandier D, Lemasson JM, Renaud O, Bouguermouh S, Vienne Md Mde L, Agius G.

J Med Virol. 2004 Jun;73(2):262-8.

PMID:
15122802
15.

Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65.

Dickson EL, Vogel RI, Geller MA, Downs LS Jr.

Gynecol Oncol. 2014 Jun;133(3):405-8. doi: 10.1016/j.ygyno.2014.03.552. Epub 2014 Mar 20.

16.

A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science.

Allameh T, Moghim S, Asadi-Zeidabadi M.

Arch Gynecol Obstet. 2011 Dec;284(6):1509-13. doi: 10.1007/s00404-011-1863-4. Epub 2011 Mar 9.

PMID:
21387088
18.

[Application of high-risk human papillomavirus testing in women with abnormal cytology].

Ou H, Bian ML, Zhang XY, Chen QY, Li M, Chen Y, Liu J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):608-11. Chinese.

19.

Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany.

Remschmidt C, Kaufmann AM, Hagemann I, Vartazarova E, Wichmann O, Deleré Y.

Int J Gynecol Cancer. 2013 Mar;23(3):519-26. doi: 10.1097/IGC.0b013e318285a4b2.

PMID:
23360813
20.

Supplemental Content

Support Center